Fulcrum Therapeutics, Inc.
SEC Filing List
FULC CIK: 0001680581
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/15/2026 | |||
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| 3 | Initial statement of beneficial ownershi... | Lehrer-graiwer Joshua | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/01/2026 | |
| 4 | Statement of changes in beneficial owner... | Lehrer-graiwer Joshua | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/01/2026 | |
| DEF 14A | Definitive proxy statements | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| ARS | Annual report to security holders | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/27/2026 | |
| 8-K | Current report filing | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/27/2026 | |
| SCHEDULE 13G/A | 03/26/2026 | ||||
| No record found. | |||||
| Load More | |||||
